BAYLOR S&W MEDICAL CENTER - IRVING — History
CCN 450079 | 3-year financial timeline | COVID resilience: 57/100
🛡️ Public data only — no PHI permitted on this instance.
$245M
Latest Revenue (FY2022)
+8.5%
Revenue CAGR (3yr)
-12.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $208M | $235M | $245M | +4.3% | +8.5% |
| Operating Expenses | $229M | $272M | $276M | +1.6% | +9.9% |
| Operating Margin | -9.9% | -15.9% | -12.8% | +19.3% | +0.0% |
| Net Income | $-21M | $-37M | $-31M | +15.8% | +0.0% |
| Licensed Beds | 204 | 205 | 205 | +0.0% | +0.2% |
| Total Patient Days | 53,602 | 58,172 | 56,371 | -3.1% | +2.6% |
| Medicare Day % | 22% | 20% | 19% | -5.7% | -6.7% |
| Medicaid Day % | 17% | 4% | 3% | -26.3% | -57.2% |
COVID Impact & Recovery
Resilience Score: 57/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +17.7% ($208M → $245M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+8.5%
This Hospital
+7.6%
State Avg
Latest Margin
-12.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $263M | -14.3% |
| FY2024 (proj) | $281M | -15.7% |
| FY2025 (proj) | $300M | -17.2% |